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THE PRIMARY STRUCTURE OF SELJOOTED PEPTIDES 
FROM CHYMOTRYPTIC DIGESTS OF NIFUNGlN 
Abstract 
:BURTON DOYN CARDWELL 
Under the supervision of Professor Oscar E. Olson 
Nifungin, an anti.fungal peptide produced by Aspergillus giganteus, 
was studied and partially characterized. 
The amino acid composition of the anti.fungal peptide was investi­
gated, and eighty-seven percent of the peptide constituents were identi­
fied. 
The presence of free -SH groups in the peptide was studied by 
spectrophotometric titration of the peptide with p-hydroJcymercuribenzoate. 
Perf"ormic acid oxidation was used to disrupt the disulf"ide bridges 
present in the molecule, and subsequent enzymatic digestion of the 
oxidized peptide was accomplished with alpha chymotrypsin. Ch:romato­
graphic separation of the digestion mixture produced eleven ceymotryptic 
peptides. Six of these peptides were selected f"or amino acid sequence 
analysis by the Eaman degradation method. 
The results of this study indicated that nifungin is a basic 
peptide containing a minimum of forty-nine amino acid residues. It 
contains no tryptophan, histidine or methionine. The peptide has no 
free -SH groups, but incorporates four disulf"ide bridges within its 
structure. The sequence studies on the six chymotryptic peptides showed 
that t?ese peptides had unusual end-group residues in some instances, 
based on the specificity of the digesting enzyme, suggesting that the 
overall nifungin structure was complex. 
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In 1956, the Division of Antibiotics and Fermentation, Michigan 
Department of Public Health Laboratories, Lansing, Michigan, initiated 
a cancer s·creening program in cooperation with the National Institutes 
of Health. The purpose of the program was to isolate from soils those 
fungi which could produce antitumor compounds with "in vivo" activity 
against selected sarcoma, carcinoma and leukemia tumor strains trans­
planted in mice. 
One of the earliest mold cultures found to produce an antibiotic 
having activity against these tumor strains was designated as Michigan 
Department of Public Health 18894 or (MDPH 18894). This mold was later 
found to be Aspergillus giganteus. The compound produced by !:_ giganteus 
was designated alpha sarcin and assigned the Cancer Chemotherapy 
National Service Center Number 46401 (CCNSC 46401). 
During the isolation and subsequent purification of alpha sarcin 
it was determined that two of the four minor peptides present in the 
crude preparation of the drug possessed antif'ungal activity against 
MDPH 134621 mold. The MDPH 134621 mold culture was another soil 
organism isolated in this same screening program and later identified 
as Aspergillus restrictus. 
The two antifungal peptides were readily separated from each other 
and from the alpha sarcin by ion exchange chromatography using Amberlite 
XE64 resin (Rohm and Haas) with sodium phosphate buffers and a convex 
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gradient elution pattern. The major antifungal peptide from this 
separation was then desalted and further purified by gel filtration 
using a column packed with Sephadex G-25 (fine). Using these methods 
of isolation and purification, a quantity of this major antifu.ngal 
peptide was stockpiled for use in this investigation. 
The antifungal peptide was initially designated as the alpha 
sarcin mold peak. However, after beginning the study of it, the Mi�h­
igan Department of Public Health petitioned the United States Adopted 
Names Council (USAN) of the American Medical Association for a sug­
gested name for the compound. The name offered by the council was 
NIFUNGIN. This name was accepted by the Michigan Department of Public 
Health and thus replaced the older designation. 
The mode of action of nifungin is not completely understood. 
However, it is believed that the peptide inhibits the growth of 
Aspergillus restrictus rather than destroying the organism. Apparently 
it is a fungistat rather than a fungicide. 
It appeared that characterization of nifungin might be helpful 
in establishing its mode of action. It was decided, therefore, that 
work should be undertaken in this direction. Efforts toward determi­
nation of its primary structure through studies on both trypsin and 
chymotrypsin digests were initiated. Mr. Marvin Withrow at South 
Dakota State University investigated the primary structure of the 
tryptic peptides from oxidized nifungin, and the author carried out the 
amino acid sequence studies reported here on the chymotryptic digests 
of oxidized nifungin. 
HISTORICAL 
- --- --- - -- -- - - ---·--·-- . .  . 
The knowledge that proteins could be cleaved in acid or base 
to produce a mixture of amino acids was known prior to 1900. However, 
the bonding arrangement between amino acids in the intact protein 
remained unknown until 1902 when the concept of the peptide bond was 
introduced. The peptide theory introduced a fifty-three year search 
which led to the determination of the first complete amino acid 
sequence of a protein molecule in 1955. It is therefore with the pep­
tide theory that we begin the historical development of the primary 
structure of proteins. 
The peptide concept of protein structure was proposed independ­
ently by Emil Fischer and F. Holmeister in 1902 (1). The validity 
of the concept lay in the following experimental observations. (a) 
Alpha amino nitrogen and free carboxyl groups, except for beta and 
gamma carboxyl groups of aspartic and glutamic acid are liberated in 
equivalent amounts from proteins on hydrolysis. (b) Simple peptides 
occur commonly in nature. (c) The biuret reaction which characterizes 
structures with peptide bonds was positive for natural proteins but 
negative after complete hydrolysis of the protein. (d) Peptides iso­
lated from partial hydrolysates of proteins were found to be identical 
to synthetic pepti�es of known constitution. 
The structure of partial hydrolysis products was thoroughly 
examined during the early research into the primary structure of 
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proteins and peptides. Most of the research done during the first 
two decades of the twentieth century was for the purpose of gathering 
evidence for proof of the peptide theory. The methods in general were 
those of classical organic chemistry and generally crude by our present 
day standards. However, these investigations provided the essential 
background knowledge for today's research on amino acid sequence 
analysis. Synge (2) in an excellent review summarized the research 
on partial hydrolysis products from 1900 to 1943. 
In 1902, Fischer and Bergell (3) reported the isolation as a 
napthalene sulfonyl derivative of a dipeptide from an acid hydrolysate 
of silk fibroin. Organic analysis of this dipeptide led them to 
describe it as glycylalanine. When they subsequently prepared the 
synthetic napthalene sulfonyl derivatives of L-glycyl-alanine and L­
alanyl-glycine and compared them to the isolated peptide neither 
corresponded exactly to the natural product in its properties. · These 
results suggested that the isolated material was actually a mixture of 
the two synthetic dipeptides. Fischer attempted to repeat the original 
isolation, but his efforts were unsuccessful because of the lack of 
dependable techniques. In a later investigation Fischer (4) con­
verted the same natural dipeptide to a diketopiperazine by condensation 
of its esters. The L-glycyl-L-alanine anhydride formed in this manner 
was identical to the synthetic products. 
Investigators such as Abderhalden, Schwarb and Bergmann carried 
out similar type research on still other partial hydrolysis products 
of silk fibroin ( 2 ) • 
The basic protamines and histones from fish sperm were also in­
vestigated during this early period. Kossel and Mathews (5) precip­
itated these compounds with phosphotu.ngstic acid, or silver nitrate, 
and carried out-primary structure studies on the trypsin hydrolysis 
products of the isolated compounds. 
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Abderhalden and Suzuki (6) -investigated the group of proteins 
known as the keratins. Goose feathers were treated with 70 percent 
sulfuric acid for 5 days at room temperature. After the complete re­
moval of the sulfuric acid with barium hydroxide, the aqueous solution 
was evaporated to dryness and extracted with boiling methyl alcohol. 
This extract gave products which were not only insoluble in water, 
but in some organic solvents as well. These products gave the charac­
teristic bi�et reaction, but did not give any other of the usual 
protein color reactions. Complete hydrolysis of the products with 
acid was unsuccessful. Abderhalden (7) later isolated a crystalline 
product from these same fractions. Complete acid hydrolysis of this 
crystalline product gave glycine, proline and a molecule of hydroxy­
proline. Abderhalden theorized that this crystalline product was an 
anhydride fonned by two molecules of proline, one molecule of hydroxy­
proline and one molecule of glycine by the elimination of four molecules 
of water. 
Osborne and Clappe (8) hydrolyzed the plant protein, gliadin, 
with sulfuric acid at room temperature. Crystallization of the hydroly­
sate with subsequent analysis indicated a dipeptide-consisting of 
proline and phenylalanine. 
Following these early investigations into the prima:rzy" structure 
of proteins, the discovery was made that there existed in nature 
certain small di- and tripeptides. Their well defined crystalline 
structure and their low molecular weight made them excellent compounds 
for study (9). The knowledge gained in identifyiz:ig the amino acids 
in the earlier more complex products was applied with great success to 
such dipeptides as carnosine and anserine and particularly to the 
tripeptide glutathione. 
Glutathione was isolated by Hopkins in 1921 from a yeast source 
(10). Quastel et al. , (11) initially described glutathione as a 
dipeptide consisting of glutamic acid and cysteine. Further, their 
description correctly indicated the dipeptide as the unusual gannna­
glutamylcysteine. Later, Hunte and Eagles (12) suggested that gluta­
thione contained a third component in its molecule. Hopkins (13) 
on this information undertook a more careful study of glutathiorie. 
Hopkins found that if he boiled the oxidized form of the pure com­
pound in water for several hours a diketopiperazine was obtained. 
He characterized this diketopiperazine as a.nhydrodiglyclcystine. 
Similar treatment of the reduced glutathione gave the same compound. 
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On this basis it appeared that a glycine residue was present in the 
peptide, and that it was directly linked to the cysteine. Glutathione 
was therefore actually a tripeptide consisting of glutamic acid, glycine 
and cysteine. Titration studies by Pirie and Pinhey (14) tentatively 
verified the gluta.mylcysteinylglycine structure of the compound. 
In 1930 the COOR-terminal position of glycine was determined 
by three separate research groups using three different methods. 
Proof that glutamic acid was in the NH2-terminal position was eSta­
blished by Gurin and Clark (15) when they converted oxidized gluta­
thione to the N,N-dibenzenesulfonyl derivative, followed by butyl 
esterification and isolated the dibutyl ester of benzenesulfonyl-
1-glutamic acid. In 1935, Harrington and Mead synthesized gluta­
thione (16). 
In spite of the success in determining the amino acid sequence 
of glutathione, Synge concluded his review of partial hydrolysis 
products with this statement (2): 11 It seems that the main obstacle 
to progress in the study of protein structure by methods of organic 
chemistry is the inadequacy of technique rather than theoretical dif­
ficulty. It is likely that the development of new methods of work 
in this field will lead us to a much clearer understanding of the 
proteins." 
The period between 1940 and 1950 was marked by increased effort 
on the part of protein chemists to develop more systematic methods 
for establishing the amino acid sequence of proteins and peptides. 
In 1945 Fox (17) reviewed the methodology for determining the terminal 
amino acid sequence in both proteins and peptides. These methods 
plus the techniques of paper chromatography developed by Consden, 
Gordon and Martin (18) marked the introduction to present day studies 
of amino acid sequences. 
7 
8 
Sanger (19) determined the first complete amino acid sequence 
of a protein in 1955. For this determination he chose the pancreatic 
hormone, insulin. 
The study of insulin began with the determination of its molecular 
weight. Osmotic pressure measurements and ultracentrifugation data 
showed the minimum molecular weight to be 12, 000. Repeating Sanger's 
experiments, Harfenist (20) obtained results which indicated that the 
molecular weight of the molecule was approximately 6000 rather than 
the 12, 000 originally proposed by Sanger. Harfenist and Craig (21) 
verified the lower molecular weight using a method of partial sub­
stitution on the insulin molecule. 
NH2
-terminal analysis of insulin by Sanger using 2,4-dinitro-l­
fluorobenzene (DNFB) yielded one residue of Dinitrophenyl (DNP) glycine 
and one residue of DNP phenylalanine (19). These results sugge�ted 
the presence of two peptide chains in the insulin molecule. COOH­
terminal analysis of insulin showed one alanine and one asparagine 
residue (19). These findings substantiated the presence of two 
separate chains in the molecule. 
Sanger was able to separate insulin into its two component chains 
by splitting the intact molecule with performic acid at the site of 
its disulfide bridges. Once split, the two resulting peptide frag­
ments were readily fractionated from each other (19). 
The oxidized insulin yielded an acidic fraction (A) which con­
tained the NH2
-terminal glycyl residue and no basic amino acids, plus 
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the more basic fraction (B) which had an NH2-terminal phenylalanyl 
residue and was insoluble at pH 6.5 (22). COOR-terminal analysis on 
both chains showed that the glycyl chain was terminated with aspara­
gine and the phenylalanyl chain with alanine. The glycyl chain con­
tained twenty amino acids, while the phenylala.nyl cha.in contained 
thirty amino acid residues. Further, four cysteic- acid residues were 
found in the glycyl chain, and two in the phenylalanyl chain. 
Sanger and Tu.ppy (23) reported the amino acid sequence of the 
phenylala.nyl chain in 1951. The phenylala.nyl chain was subjected to 
partial hydrolysis in acid and alkali and the resulting peptide mixture 
was separated by paper chromatography using the methods of Consden, 
et al. (18). NH
2
-terminal groups were identified and several amino 
acid sequences were detennined. The entire sequence of the phenyl­
alanine chain could not be dete:rmined because of the difficulty which 
occurred in the fractionation of some of the non-polar peptides. 
Sanger and Tu.ppy (23) in an effort to avert these difficulties 
next digested the phenylalanyl chain with the proteolytic enzymes, 
pepsin, chymotrypsin and trypsin, fractionated the resulting peptides 
by paper chromatography, and from the terminal analysis data obtained, 
were able to determine the complete structure of the phenylala.nyl 
chain. 
The presence of more hydrophobic amino acid residues in the 
glycyl chain made its structure more difficult to determine. Sanger 
et al., reported its sequence in two papers (24,25). The first paper 
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discussed the peptides obtained by partial hydrolysis with strong 
acid, while the second was devoted to the larger peptides obtained 
by enzymatic digestion with pepsin and chymotrypsin. Separation of 
the peptides was accomplished by ionophoresis on silica gel and they 
were identified further by paper chromatography using 2,4 dinitro-1-
fluorobenzene. The sequences obtained after acid hydrolysis plus 
those obtained from the peptides after enzymatic action were enough 
to deduce the complete sequence of glycyl chain. 
The sequence of both chains (A and B) of insulin was now known. 
However, two problems remained: (1) allocation of the amide groups 
to particular dicarboxylic amino acid residues, and (2) the assignment 
of the position of the cystine molecules in the original insulin com­
pound. 
Sanger, et al. , (26) determined the location of the amide groups 
by comparing ionophoretically, those peptides from enzymatic digests havi�g 
intact amide groups with those of acid hydrolysates in which the amide 
group had been split off. The relative rates of migration gave an 
indication as to the presence of charged groups on the peptides and 
also suggested the number of carboxyl groups masked as amides. 
Ryle, et al. , (27) determined the position of the disulfide 
bridges in insulin. They subjected the intact insulin to partial 
hydrolysis and fractionated the resulting cystine containing peptides 
from one another. These peptides were then oxidized with performic 
acid and the cysteic acid peptides obtained were identified. Through 
comparison of the amino acid sequences in these peptides with those 
of the tryptic and chymotryptic peptides of the A and B chain the 
disulfide bridge locations were determined. 
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Once the disulfide bonds were located, it became a matter of fit­
ting all the pieces of the compound together to complete the sequence. 
The general methods used by Sanger to determine the primary 
structure of insulin established the pattern for all subsequent amino 
acid sequence determinations. These methods included (a) determination 
of the amino acid composition of the peptide or protein, (b) NH2-
terrninal and COOR-terminal group determination of the peptide, (c) 
oxidation of the disulfide bonds in the protein structure, (d) enzy­
matic degradation of the oxidized protein, (e) separation and puri­
fication of the peptide mixture, (f) determination of the amino acid 
composition and sequence of each peptide fragment, (g) determination of · 
location of the disulfide bridges, (h) fitting together the complete 
sequence from the sequence of overlapping peptides obtained from the 
digestiori of the protein with two or more enzymes. 
The second major achievement in the establishment of amino acid 
sequences for proteins was the work of Hirs, et al. on ribonuclease (28). 
This single-chain enzyme, composed of 124 amino acids and containing 
four intrachain disulfide bridges was approached in a manner similar 
to that employed for insulin. Hirs (29) disrupted the bridges with 
performic acid, and Moore and Stein (28) digested the oxidized ribo­
nuclease with trypsin and chymotrypsin in separate experiments. The 
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resulting peptide mixtures were separated on Dowex 50 x 2 ion exchange 
resin using volatile pyridine acetate buffers of varying concentrations 
and ionic strengths. 
Moore and Stein et al., (30) determined the amino acid sequences 
of the small tryptic and chymotryptic peptides of ribonuclease. The 
PNFB method a!ld the ne�er. _Ed�an. �egrad�t_ion __ (31). w_hich _inv_olveq_ the 
formation of cyclic phenylhydantoins was used to determine the amino 
terminal sequences (31). The sequence of COOR-terminal amino acids was 
determined with carboxylpeptidase A and B. The overlapping sequences 
of the various peptides were then fitted together to complete the 
protein structure. 
The use of Dowex 50 x 2 ion exchange resin for the separation of 
low molecular weight peptides and the automatic amino acid analyzer 
developed by Spackman, Moore and Stein (32) for the quantitative 
determination of the amino acid composition of the peptides were the 
principal advances in technique employed to establish the primary 
structure of this larger protein. 
The Dowex 50 x 2 is a strongly cationic, sulfonated polystyrene 
ion exchange resin crosslinked with 2% divinylbenzene. The percentage 
of divinylbenzene used in the resin network determines the porosity of 
the resin, and thus the size of the peptides which are resolved best 
by the resin. 
Dowex 50 x 8 gives excellent resolution of di- and tripeptide 
mixtures, however for peptides containing 4-7 residues the Dowex 
50 x 4 resin becomes more practical. The Dowex 50 x 2 resin is pre­
ferred for peptides of 8-10 amino acid residues. The lower percent­
age of divinylbenzene incorporated into the resin allows the high 
molecular weight peptides to enter the resin matrix where exchange 
can occur. 
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Since the clarification of the complete structures of insulin and 
ribonuclease, the structure of numerous other proteins and peptides 
have been established. Eck and Dayhoff (33) have compiled an atlas 
of most of the published and some unpublished partial and complete 
amino acid sequences. 
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MATERIALS 
Equipment - .Amino acid analyses were made using a Beclanan Model 
120 B Amino Acid Analyzer as described by Spaclanan (34). Absorbance 
measurements were carried out with a Cary Model 14 Recording Spectro­
photometer having matching quartz sample and reference cuvettes. A 
Sargent Model S 30240 Recording pH Stat with combination pH electrodes, 
autdmatic temperature control and stirring unit, was used for deter­
mining the rate of enzyme reaction. The Model V-10 automatic fraction 
collector, with a 200 fraction turntable capacity was used for the 
collection of eluates. Peptide samples were lyophilized using a 
Buchler cold finger condenser having five lyophilizing flasks. Reduced 
pressure WqS maintained with a Welch Duoseal Vacuum pump. 
Chemical Reagents - All inorganic and organic chemicals used in 
the preparation of solutions for this investigation were reagent 
grade unless otherwise specified. Manufacturer and specification of 
reagents will be described in the proper sections under Methods. 
Buffer solutions used in this investigation will also be described in 
the proper sections under Methods. 
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METHODS 
Isolation and Purification of Nifungin - The antifungal peptide, 
nifungin, used in this investigation was isolated and purified by Olson 
and Goerner using the methods described by them in 1965 (35). 
The moisture content of the peptide, determined by drying to a 
constant weight at 105° , was 0. 0%. Its ash content, 1. 49%, was deter­
mined by heating 40. 2 mg of the peptide at 600° for two hours in a 
small platinum crucible and weighing the residue. 
The ultraviolet absorption spectrum of nifungin showed a single 
0 0 
absorption maximum at 2780 A and a minimum at 2540 A. It had been 
found that the quantity of the peptide in a solution could be deter­
mined from the ultraviolet spectrum by using the method of Camiener 
et al. (36). Using this method, the spectrum of a solution containing 
the peptide was run on the Cary Model 14 Spectrophotometer and a tangent 
was drawn common to the curve at the minimum near 2500 A and the in-
0 0 
flection near 3050 A. The height of the curve above this line at 2800 A 
was used as a measure of the peptide. content of the solution. The 
purified nifungin used in this study gave 113 absorption-height units 
per mg. This value had been found by Olson and Goerner (35) to be rep­
resentative of pure nifungin. 
Amino Acid Analysis - Amino acid analyses on acid hydrolysates 
were made as described by Spaclanan et al. (34) with the use of the 
Spinco Model 120 B Amino Acid Analyzer. 
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The amino acid content of the nifungin was determined on acid 
hydrolysates prepared as follows: A 1.00 ml aliquot of a solution 
containing 1. 2 mg of ni.fungin per ml was added to each of four 20 ml 
heavy walled Pyrex ampoules, frozen and lyophilized, then 0.9 ml of 
constant boiling HCl was added to each ampoule, and after freezing its 
contents in a dry ice-alcohol bath and evacuating the ampoule it was 
sealed at the neck with an oxygen flame. T.he ampoules were then placed 
in a 120 ° gravity convection ov n and one tube was withdrawn at each 
20,40,70 and 116 hours. After removing and cooling, each tube was placed 
in a dry ice-alcoho bath for about 10 minutes, the seal was broken, 
and the tube lyophilized. After adding 5.00 ml of diluting buffer, 
pH 2.2 (34), 2.00 ml was used for amino acid analysis on both the short 
and the long umns of the analyzer. The analyzer was standardized 
using :Beckman amino acid calibration mixture fype 1 ju.st before and 
just after the e.nalysis of the hydrolysates and average "C" values 
were used in making calculations. 
No tryptophan was noted on analysis of the acid hydrolysates. 
However, because of the lability of this amino acid during acid hydroly­
sis, the method f Beneze and chmidt (37) was used in an effort to 
detect tryptophan in the intact peptide. Barium hydroxide hydroly­
sates (38) were also examined on the amino acid analyzer. 
Oxidation of Nifungin with Perfonnic Acid - Ni.fun.gin was oxidized 
with performic acid accordi g to the method of Hirs (29). 
Performic acid was prepared by mixing formic acid, 97-100% 
(Matheson, Coleman Bell: Norwood, Ohio) with 30% hydrogen peroxide, 
(Mallinckrodt Chemical Works, St. Louis, Missouri) in the ratio of 
19: 1. The solution was carefully agitated and allowed to stand open 
at room temperature for two hours. 
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A 1. 00 g portion of nifungin was dissolved in 25 ml of formic 
acid (97-100%) and trans"ferred to a 250 ml volumetric flask which 
served as the reaction vessel. To prevent the freezing of reactants 
during the oxidation period, 5. 0 ml anhydrous methanol was also added 
to the reaction vessel. 
After two hours, the solution of performic acid was covered and 
placed in the cold room at 4° . At the same time, the reaction vessel 
containing nifungin was immersed in an alcohol bath maintained at -10° 
by a cold finger containing dry ice. After 30 minutes, the performic 
acid solution was removed from the cold room and 93. 5 ml was trans­
ferred to the reaction vessel. This volume represented a portion 
equivalent to twelve times the amount of acid necessary to effect 
complete oxidation of four disulfide bonds. The reaction mixture was 
agitated in the reaction vessel and the oxidation was allowed to pro­
ceed for 2. 5 hours at -10° . After this period, the reaction mixture 
was transferred quantitatively into 200 ml of distilled water at 4° 
with several rinsings. The solution was mixed thoroughly, and then 
divided equally between four round-bottomed lyophilizing flasks, 
shell frozen and freeze dried for 24 hours. The drying procedure was 
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then repeated after redissolving the dried oxidized peptide in 40 ml 
of cold distilled water. After the final drying, the oxidized peptide 
was transferred to a·tared screw cap tube and its weight determined 
at 934 mg. 
Amino acid analysis of the peptide after oxidation indicated the 
presence of 8 _moles of cysteic acid and the complete absence of half­
cystine residues in the molecule. This showed that the oxidation of 
the disulfide bonds was essentially complete. Except for the oxidation 
of half-cystine, the amino acid composition of the peptide was not 
changed by the oxidation. 
Digestion of Nifungin with Alpha Chymotrypsin - Alpha chymotrypsin 
(3. 4. 4. 5. , W9rthtngton, LOT No. CDl 6093) was used to hydrolyze the 
oxidized nifungin into shorter peptides for sequence studies. The 
alpha chymotrypsin was assayed for activity by the method of Hummel (39). 
Its activity was found to be 11 units/mg. This is essentially the 
activity expected of crystalline alpha chymotrypsin (39). 
The peptide (934 mg) was dissolved in 93 ml of distilled deionized 
water. The temperature of the solution was adjusted to 37° and main­
tained there using the automatic temperature controller on the Sargent 
Recording pH Stat. When the temperature stabilized at 37° , the pH 
of' the solution was adjusted to 8. 0 using 0. 1 N NaOH. At zero time 
19 ml of a 1% solution of chymotrypsin in 0. 001 N HCl was added via 
pipette, giving a 50:1 substrate - enzyme ratio. 
The rate of enzyme reaction was measured as the amount of 0. 1 N 
19 
Na0H required to maintain the pH of the solution at 8. 0 (Fig. 1). 
The Sargent Recording pH Stat was used . for automatic pH and temperature 
control. The reaction was carried out for 24 hours and additional 10 
ml of enzyme solution was ad�ed after 4 hours. The reaction was ter­
minated at the end of the digestion period by adjusting the pH to 2. 0 
with 1 N HCl to inactivate the enzyme. The pH of the mixture was then 
raised to 7. 0 with 1 N Na0H and the hydrolysate was transferred quanti­
tatively to a round-bottomed lyophilizing flask. The hydrolysate was 
shell frozen and freeze dried for 24 hours. The dried peptide was trans­
ferred to a sterile screw cap tube and held under refrigeration. 
Chromatographic Separation of Peptides - The chymotryptic peptides 
were separated by ion exchange chromatography using Amberlite XE64 resin 
(Rohm and Haas). A 2. 2 cm x 160 cm column was packed to a resin bed 
height of 150 cm with the Amberli te resin. The resin was th.en equili­
brated with 0. 1 M ammonium acetate buffer at pH 5. 92. The dried peptide 
digest was dissolved in 20 ml of this same buffer and applied to the 
top of the column. The column was eluted with a convex gradient system 
consisting of 0. 1 M annnonium acetate buffer pH 5. 92 in the mixing vessel 
(2, 200 ml) and 0. 9 M ammonium acetate pH 6. 0 in the reservoir. Because 
of the column height, a metering pump was placed between the mixer and 
the top of the column to insure a flow rate of 80 ml per hour. 
A total of 440 eluates containing 10 ml per tube was collected 
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Figure 2 Chromatographic separation of the chymotryptic peptides from 
595 mg of nifungin on Amberlite XE64 resin. Elution was 
carried out using a convex gradient elution from 0.1 M 
phosphate buffer pH 5.97 in the starting mixer (2140 ml) to 
0. 9 M phosphate buffer pH 6.02 in the reservoir. Twenty ml 
fraction� were collected. Optical densities were
0
determined 
at 2760 A (--) in the ultraviolet, and at 5700 A (---) in 
visible region after reaction with ninhydrin. The ninhydrin 
assay was carried out according to Moore and Stein (40) 









q 2. 0 
H 
8 
� 1 . 5 
1 .  












' '  








- -- - - � .J  
22 
o . o - -
- -
20 40 60 80 100 120 
FRACTION NUMBER 
Figure 3 Chromatographic separation of the chymotryptic peptides from 
523 mg of nifungin on Arnberlite XE64 resin. Elution was 
carried out using a convex gradient elution from 0. 1 M 
phosphate buffer pH 5. 97 in the starting mixer (2140 ml) to 
0. 9 M phosphate buffer pH 6. 02 in the reservoir. Twenty ml 
fractions were collected. Optical densities were determined 
0 0 
at 2760 A (--) in the ultraviolet, and at 5700 A (---) in 
visible region after reaction with ninhydrin. The ninhydrin 
assay was carried out according to Moore and Stein (40) 
using 0. 5 ml of sample. 
were determined at 2760  A on the Cary Model 14  spectrophotometer . 
Preliminary studies on the peptides in the elution profile showed good 
0 
2 3  
correlation between the ultraviolet absorption at 2 760 A and the visible 
0 
absorption at 5700 A after reaction with ninhydr in . (See Figs. 2 and 3) . 
Based on these studies ninhydr in was used only to determine peptide 
AF-9 which possessed no measurable absorption in the ultraviolet at 
0 0 
2760 A, but absorbed readily at 5700 A following the reaction w ith 
ninhydrin.  ( See Figure 4) . 
Ninhydrin Assay - The method used was descr ibed by Moore and 
Stein (40) and the ninhydr in solution was prepared in a manner similar 
to that used in the Model 1 20 B amino acid analyzer . 
For analysis, 0 . 5 ml of effluent fractions were pipetted into 
clean 3 inch test tubes . The test tubes were covered w ith gauze and 
the solutions quick frozen and lyophilized for 1 6  hours to remove 
excess ammonia . Following lyophilization, the fractions were recon­
stitued with 5 . 0  ml of distilled water . One ml of ninhydr in solution 
was added to each tube . The tubes were capped, shaken and then heated 
in a boil ing water bath for 15 minutes. After development of the 
character istic purple color the contents of the tubes were cooled ,  
and d iluted with 5 ml of ethanol-water (1 :1) and shaken vigorously, 
0 
the absorbance of each was determined at 5700 A on the spectrophotom-
eter . 
The Edman Degradation - The Edman degradation of the chymotryptic 
:>-i 
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Figure 4 Location of Peptide AF-9 Using 




peptides from nifungin was carried out as described by Daphiede, Moore 
and Stein (41). The entire reaction series for each peptide was ac­
complished in a 15 ml serum vial covered with a 1" x 1" teflon square 
as a vapor barrier and a rubber stopper . 
Approximately 10 uM ·of each peptide was dissolved in 1 . 0  ml of 
pyridine-water-N-ethylmorpholine (150: 100: 29) (Pyridine: P368 Fischer 
Scientific Co . ,  Fair Lawn, New Jersey: N-ethylmorpholine: P7832, 
Matheson, Coleman Bell, Norwood, Ohio) which had been adjusted to 
pH 8. 5 with glacial acetic acid. The peptide solution was bathed for 
30 seconds with prepurified nitrogen, the vial covered with the tenon 
square and loosely stoppered. One hundred microliters of phenylisothio­
cyanate (Px 800, Matheson, Coleman Bell, Norwood, Ohio) was added to 
each vial, the solution was thoroughly mixed, and the contents of the 
vial were again .bathed with nitrogen for 30 seconds .  The vial was 
covered, stoppered, capped with an aluminum overseal and incubated at 
40° in a controlled temperature bath for 2. 5 hours with agitation every 
15  minutes. After· incubation, the vial was opened and the phenyl thio-
c arbanzy-1 peptide was extracted five· times with 2. 0 ml of water saturated 
with benzene (No. 3856, Thiophene Free, B . P. 80. 1 ° Mallinckrodt Chemical 
Works, st. Louis, Missouri). After each extraction the �pper solvent 
phase was quick frozen in dry ice and alcohol. The vial was covered 
with gauze and the peptide was lyophilized overnight to remove the excess 
benzene. After lyophilization the peptide sample was dissolved in 0 .1  M 
26 
of trifluoroacetic acid (No. 7454, B .P. 71-73° Matheson, Coleman Bell, 
Norwood, Ohio) and bathed again with nitrogen. The vial was sealed again 
and allowed to remain at room temperature for one hour. The vial was 
then opened and the excess trifluoroacetic acid was removed under a 
stream of nitrogen. The time required for this was 2-3 minutes. One ml 
of 0. 4 M acetic acid was added to the vial, and the resulting solution 
extracted three times with 2. 0 ml of benzene saturated with 0. 4 M acetic 
acid to remove the phenylthiohydantoin. After extraction a suitable 
aliquot was removed from the vial for acid hydrolysis and amino acid 
analysis. The remainder of the peptide was lyophilized in preparation 
for the next degradation. 
For the amino acid analysis, an aliquot (0. 1 - 0. 5 ml) of the 
peptide after each Edman degradation step was placed in a 3 inch test 
tube. The Sarr4)le was quick frozen and lyophilized for 16 hours to 
remove excess solvent. The dried peptide in the tube was dissolved 
in 2. 0 ml of 6N HCl and cooled. The tube was sealed under vacuum and 
the sample was hydrolyzed for 24 hours at 110° in a gravity convection 
oven. At the end of the hydrolysis period, the tube was opened, and 
the sample was transferred quantitatively to a 25 ml round-bottomed 
flask. Excess hydrochloric acid was removed on the rotary evaporator, 
and the peptide sample was dissolved in 2. 1 ml of pH 2. 2 diluting buffer. 
The peptide s�le (1. 0  ml/column) was then run on the amino acid 
analyzer. 
The complete amino acid composition of each purified peptide had 
been determined previously by amino acid analysis. For each succes­
sive Edman degradation of an individual peptide the NH2
-terminal 
2 7  
amino acid was removed as  the cyclic phenylthiohydantoin in the dis­
carded solvent phase. The original amino acid chromatogram for each 
peptide was compared quantitatively with the chromatogram obtained after 
each stage of Edman degradation. · The amino acid " subtracted" or greatly 
reduced on successive chromatograms_ was asswned to be the NH
2
-terminal 
amino acid for that stage of the degradation. For (n) number of amino 
acids, the subtractive method was carried out (n-1) times. 
-SH Group Determination - The free -SH groups in unoxidized 
nifungin were determined by spectrophotometric titration of the 
peptide at pH 7. 0 and 4 . 6  using p-hydroxymercuribenzoate ( 4 2) . 
28 
For analysis , 3. 0  ml of 6 . 4  x 10-5 N p-hydroxymercuribenzoate in 
0. 05  M phosphate buffer pH 7. 0, previously standardized with 5. 7 x 10-3 
N reduced glutathione , was pipetted into the 1. 0 cm quartz sample cuvette 
in the Beckman DU spectrophotometer. An equal volume of 0. 05 M phosphate 
buffer pH 7. 0 alone was placed in the matching reference cuvette, and 
the absorption of the p-hydroxymercuribenzoate was determined at 250 mu. 
To titrate, identical increments of the . 0057 M peptide solution were 
added to both the cuvette containing the known quantity of buffered p­
hydroxymercuribenzoate and to the reference cuvette containing buffer. 
After mixing·, the change in absorption with the addition of peptide was 
measured at 250 mu and recorded. With the addition of pepti�e incre­
ments , resulting absorption readings were corrected for dilution. The 
end point of the ti tra tion is normally reached when the slope of the 
absorption curve becomes zero. The titration was repeated at pH 4 . 6 
to determine the presence of total -SH groups. 
RESULTS 
Amino Acid Composition of Purified Nifungin - The amino acid 
composition of nifungin after acid hydrolysis is given in Table I. 
2 9  
For each hydrolysis period the number o f  micromoles o f  each amino acid 
residue present per mg of nifungin was calculated. Based on time study 
results either a maximum value per residue or an average extrapolated 
value for the number of micromoles per weight of sample was determined 
( Footnote �, Table I). 
The amino acid residues accounted for slightly over 85% of the 
peptide, with ash and moisture content contributing an additional 1 . 5% 
to the composition. Approximately 13% was undetermined. Unpublished 
studies ruled _ out the presence of phosphate ion, reducing sugars or 
tryptophan. The . appearance of an unknown peak in each of the amino 
acid chromatograms was continually noted . The unknown peak was located 
in the chromatograms from the lS cm chromatographic column in the region 
immediately preceding the lysine residue. The identity of the material 




Lysine 1 .6860 
( suppressed).! 




Aspartic 0 . 7430 
acid 
Threonine 0.2643 






Half cystine 1 .1324 
Valine 0.1489 
Table I 
Amino acid co�osition of niftmgin after acid hydrolysis 
micromoles of amino acid residue per mg nif'ungin Amino acid residues 
46 hr 
1.6942 
1 . 8453 
0 .000 
o.1464 
o .  7394 
0 .23n 
0 .1709 









o hr 120 hr 
1 .  7220 1 . 7170 
1. 7608 1 .8043 
0.000 0.000 
0.1398 0.1389 
0 . 7335 o. 7417 
0 .1954 o .u6o 
0.1107 0.0344 
0 .2890 0 .2919 
0.1714 o.1na 
o.S96o o .6006 
0.596o 0 .6011 
0 .4932 0.5133 
0 .1,00 o .147j 
per J'IX)le of nifungin 
Average or (mininllln) 
extrapglated 




1 .  7048 11 . 76 12 
1 . 8cX)3 12 . 24 12 
0.000 o.oo 0 
0.1484* 1 .01 1 
o .  7394 5.03 5 
0 .2984* 2 .03 2 
0.3000* 2 .04 2 
0.2919 1 . 98 2 
0 .1694 1 .1, 1 
0.5948 4.04 4 
0.5953 4 .05 4 
1 .1763* 8 .00 8 

















Methionine 0 . 0000  
I soleucine 0 . 2959 
Leucine 0 . 0000  
Tyrosine 0 . 8142 
Phenyl-
alanine 0 .14.ll 
Tryptophan 0 .0000 
Amroonia 0 . 6782 
Footnotes to Table 
0 .0000 
0 . 2953 
0 . 0000 
0 . 7801 
0 .1388 
0 . 0000 
0 . 7466 
! Data from suppressed 570 nm 
0 . 0000  
0 . 3002 
0 . 0000 
0 . 7457 
0 .1367 
0 .0000 
1 . 1167 
0 . 0000  
0 . 2890 
0 . 0000 
0 . 5696 
0 . 1385 
0 . 0000 
1 . 2096 
0 . 0000 
0 . 2951 
0 . 0000 
o . 8824 
0 .1388 
0 . 0000 
0 ,5756 
Corrected - - 0 . 5405 
b Data from normal 570 obtained by dilution of san:ple 
0 . 00 0 
2 . 00 2 
0 . 00 0 
6 . 00  6 
0 . 94 1 
51 
0 . 0000 
3 . 67 4 
c Except for those values marked by an asterisk, the data in this column are averages .  Those 
- values marked by an asterisk were obtained by extrapolation to zero time . 
0 . 00000 
0 . 03339 
0 . 00000 
0 . 14398 
0 . 02043 
o . 8583 7 
d Since the roolecular weight of the antifungal peptide was not know, this column was calculated 
by assuming from inspection of the data that the peptide contained the number of residues in­
dicated below, dividing the microrooles of the amino acid per milligram of nifungin by this nUIJi:ler 
and taking the average of the values obtained . 
Amino Acid Asswned 11¥/� Factor 
Lysine 12 0 . 1500 
Aspartic A cid 5 0 . 1479 
Glutamic Acid 2 0 .1460 
Glycine 4 o . 1487 
Alanine 4 0 .1488 
Valine 1 0 . 1491 
Isoleucine 2 0 . 1476 
Phenylalanine 1 0 . 1388 
Average - - 0 .1471 
Separation and Purification of the Chymotryptic Peptides - The 
32 
results of the chromatographic separation of the chyrnotryptic peptides 
from oxidized nifungin are shown in Figure S . . 
The acidic peptides AF- 1 through AF-6 were eluted in rapid suc­
cession after the column was started. Peptide AF- 1 was a yellowish 
colored peak which appeared in those eluates corresponding to the void 
volume of the ion exchange column. All of the other peptides were 
colorless. Peptides AF-1 through AF-6 all required further purification 
by ion exchange chromatography. 
The peptides AF-7  through AF-11 appeared to be resolved well 
enough that further purification was unnecessary. The tubes containing 
each of these peptides were therefore pooled. Each pool included those 
eluates on both sides of the peak whose optical density at 2760 A was 
equal to or greater than the optical density representing one-half the 
height of the peak tube. The pooling was done in this manner to ob­
tain the most homogenous sampling possible for each of the peptides. 
The volume of each pool was determined, and the solution was filtered 
through a 28 nun millipore filter pad, using a small Buchner funnel. 
Each peptide pool was then transferred quantitatively to a previously 
tared 3 0  ml sterile screw-cap tube. The tubes were immediately covered 
with two layers of gauze and the solutions shell frozen in an alcohol­
dry ice bath, and lyophilized for forty-eight hours. After lyophiliza­
tion, the dried peptides were immediately weighed, and placed under 
refrigera tion. 
� -
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Figure 5 The Chromatographic Separation of the Chymotryptic Peptides 
from nifungin on Amberlite XE64 I on Exchange Resin 
AF-11 
400 420 440 
\..,J w 
Peptide AF-1 was contained in the pool of eluates J5 through 
43 . I t  was yellowish in ·color with some turbidity. Attempts to 
purify this peak further were unsuccessful. Using arrrrnoniurn ion 
concentrations from 0. 001 M to 0. 1 M at pH 5 . 95 both direct elution 
34 
and gradient elution failed to resolve this peptide from the contam­
inating peptides AF-2 and AF-3. The pooled solut_ions containing it and 
the contaminants were filtered through a millipore filter pad using a 
small Buchner funnel and transferred quantitatively to a 250 ml round­
bottomed lyophilizing flask. The solution was sheil frozen and sub­
sequently lyophilized for 48 hours. The dried peptide residue was 
yellowish tan in color and appeared as thin translucent flakes in the 
bottom of the lyophilizing fl�sk • .It was carefully transferred to a 
sterile JO ml screw cap tube; the tube was tightly capped and then 
stored under refrigeration at 4 ° . 
The sequence of amino acids in peptide AF-1 was not determined 
because the compound was not sufficiently pure. This peptide was 
useful however in helping to locate those amino acids which were 
present in the original antifungal peptide as single residues. Arginine , 
proline, valine and phenylalanine were all found in peptide AF-1 at a 
significant level, while these same residues did not appear in any of 
the other peptides in more than trace amounts. 
Peptides AF'-2 and AF-3 were found in eluates 40 through 50 in 
the original separation (Figure 5) . These peptides were masked 
under what appeared to be a single large peak which had an optical 
35 
density of 5. 0 at 2760 A. The acidity of this peptide fraction, 
based on its position in the elution pattern, suggested that the 
strongly acidic sulfonic acid resin, Dowex 50 W x 2 (Dow Chemical Co. ) 
could be used to separate any peptides present. Preliminary studies 
on the Dowex 50 W x 2 using ammonium acetate buffers at pH J . 8 were 
successful in achieving this separation. 
The pool (120 ml) which contained the combined peptides AF-2 and 
AF-3 was quantitatively transferre_d to a .500 ml round-bottomed flask 
and evaporated to dryness on the Buchler rotary evaporator. The dried 
residue was reconstituted in 20. 0 ml of 0. 02 M ammonium acetate buffer 
at pH J . 8 .  This sample was immediately applied to the top of a 2. 0 x 
60 cm Dowex .50 W x 2 ion exchange column which had been equilibrated 
with 0. 02 M ammonium acetate buffer pH J . 8 . The solution was allowed 
to percolate into the resin matrix. The resin surface was then rinsed 
twice with 1. 0 ml of the equilibrating buffer. The column was eluted 
with a gradient system consisting of 0. 02 M ammonium acetate buffer 
pH J. 8 in the mixer (1000 ml) and 0. 3 M ammonium acetate buffer pH 3. 8 
in the reservoir. Ten ml eluates were collected using the Gilson auto­
matic fraction collector at a flow rate of 60 ml per hour . A total of 
60 fractions was collected. The optical density of each fraction was 
determined at 276o A and plotted as a function of the eluates collected 
( Figure 6) .  
Peptide AF-4 was originally believed to be contaminated with 
ano ther pl�ptide fragment. Because of this, attempted purification 
H 
Cl) 
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Figure 6 Chromatographic Separation of Peptide AF-2 




of the peptides - was carried out as follows . 
Eluates 54 through 75 -(Figure 5) appeared to include two peaks. 
The first of these peaks was not well defined and appeared as a small 
forepeak to the larger, better defined second peak. These 21 eluates 
were pooled, filtered and held frozen prior to purification. The pool 
was thawed and evaporated to 25 ml with a Buchler rotary evaporator. 
The remaining volume was transferred to a round-bottomed lyophilizing 
flask and freeze dried for 24 hours. After drying, the residue was 
reconstituted in 10 ml of 0. 1 M ammonium acetate buffer at pH 5. 92. 
The solution was then carefully applied to the top of a 2. 0 cm x 60 
cm Amberlite XE6 4 ion exchange column. The column had been previously 
equilibrated with 2 liters of 0. 1 M ammonium acetate eluting buffer. 
The sample was rinsed into the column with 0 . 1 M ammonium acetate 
buffer pH 5. 92 and the column was eluted directly with the same buffer . 
Forty-two fractions were collected on the Gilson automatic fraction 
collector. The optical density of each fraction was determined at 2760 A 
on the Cary spectrophotometer. The elution profile obtained from the 
optical densities is shown in Figure 7 . This pattern was not essentially 
different from the separation in the original chromatogram of the 
peptide fragments. The direct elution appeared to give better defini­
tion to the peaks, however, a further separation was attempted . 
Tubes 18 through 28 from this separation were pooled and the 
volume reduced to 10 ml on the rotary evaporator . The solution was 
quantitatively transferred to the top of another 2. 0 cm x 60 cm 
� � 
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Figure 7 Ini tial Separation of Peptide AF-4 on 
Amberli te XE64 I on Exchange Resin 
J8 
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Amberlite XE64 ion exchange column. For this separation, elution was 
accomplished with a convex gradient system consisting of 0. 01 M am­
moniillTl acetate buffer pH 5. 82 in the mixing vessel (1, 000 ml) and 0. 1 M 
arrirnoniillTl acetate buffer pH 5 . 82 in . the reservoir . A total of 168 
fractions were collected, each with a volume of 10 ml . After fraction 
130 had been collected, the column was eluted directly with 0. 2 M. 
ammonium acetate pH 5. 82 to remove any peptide material which might 
be adsorbed onto the column. This concentration was selected based on 
the calculated concentration at which peptide AF-4 had been eluted from 
the original column in Figure S .  The optical density appeared as a 
s•ingle sharp peak in eluates 29 through 34, with no other peaks appear­
ing in the chromatogram through eluate 168. Tubes 29 through 34 were 
carefully pooled and rinsed several times with distilled water the final 
volume of the pool was 50 ml .  The solution was filtered t�ough a 
sterile millipore filter pad directly into a sterile tared screw cap tube. 
The tube was covered with a single layer of gauze and quick frozen in a 
dry-ice alcohol bath. The peptide was lyophilized for 48 hours after 
which the tube was tightly capped and weighed on the analytical balance. 
The dried peptide AF-4 was stored at 4° . 
Peptide AF-5 was not well separated from peptide AF-6 in the 
original chromatographic separation . To achieve further purification, 
�ubes 76 through 110 (Figure 5) were pooled and dried under vacuum on 
the Buchler rotary evaporator. The dried residue was redissolved in 
2 0  ml of deionized water and transferred quantitatively to a 250 ml 
2 . 5  
2. 0 
0 . 5 
0. 0 
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Figure 8 Final Chromatographic Separation oi· 
Peptide AF-4  on Amberlite XE64 
Ion Exchange Resin 
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lyophilizing flask. The solution was shell frozen in the flask and 
lyophilized for 24 hours. After drying, the flasks were stoppered and 
held under refrigeration. 
The dried AF-S and AF-6 peptides were reconsti tuted in 10  ml of 
0. 2 M ammonium acetate buffer pH S. 92 and rechromatographed on a 2. 2 x 
160 cm ion exchange column using a 1.50 cm resin bed of Amberlite XE64 
+ 
in the NH4 form. Separation was carried out using a gradient elution 
of 0. 2 M ammonium acetate buffer pH S. 92 in the mixing chamber (2. 200 ml) 
and 0. 6 M acetate buffer at the same pH in the reservoir. A total of 
136 eluates was collected in 10 ml fractions and the optical densities 
of the eluates determined at 276o A as shown in Figure 9. 
Using the gradient elution described, peptide AF-S was separated 
almost completely from peptide AF-6. Before peptide AF-6 was pooled, 
1. 0 ml of the peak tube (No . 79) was removed for acid hydrolysis and 
amino acid analysis ( See amino acid composition). Tubes 76 through 84 
were pooled with careful rinsing of each tube with deionized water. 
The final volume of the pool was 100 ml. The pool was then reduced in 
volume to SO ml on the Buchler rotary evaporator, filtered through a 
28 mm millipore filter pad using a small Buchner funnel and trans­
ferred directly to a 2.50 ml lyophilizing flask. The solution was 
lyophilized and stored as previously described. 
Peptide AF- 6  was prepared by pooling eluates 86 through 102, 
( Figure 9) filtering through a millipore filter pad and lyophilizing 
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Figure 9 Chromatographic Separation of Peptides 
AF-5 and AF-6 on Amberlite XE64 




ammonium acetate buffer pH 5 . 9 2  and chromatographed on a 2. 0 x 60 cm 
+ 
column of Amberlite XE64 in the NH4 form. The purification of the 
peptide AF-6 was carried out with an initial direct elution of the column 
using 0 . 2 M ammonium acetate pH 5. 92. After 110 ml had been collected, 
a small mixer (200 ml) was added to the system and the separation was 
continued using a shallow gradient from 0 . 2 M to 0 . 4 M with ammonium 
acetate buffers at pH 5. 92. A total of 105 tubes was collected and 
the optical densities of the eluates were determined as previously 
described . The elution profile of peptide AF-6 is shown in Figure 10 . 
One ml of tube 36 was removed for acid hydrolysis and amino acid 
analysis . Tubes 30 through 36 were pooled . The solution was filtered, 
lyophilized and stored as previously described . 
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An).ino Acid Composition of the C hymotryp
tic Peptides - The amino
 
acid composition of the chymotryptic p
eptides from nifungin is gi
ven 
in Table II . The acid hydrolysis and
 analysis of each peptide w
as 
accomplished as follows : ( a) T en per
cent ( 1 . 0  ml) from each of 
the 
peak tubes was lyophilized overnight 
in a clean tube to remove ex
cess  
ammonia . (b) The dried peptide was t
hen dissolve d  in 2 . 0 ml of 6 
N HCl 
and hydrolyze d  for 24 hours at 110
° after evacuating and sealing 
the 
tube . ( c) The resulting hydrolysate 
was evaporate d  to dryness  und
er 
reduce d  pressure and the re sidue re
constituted with 2 . 0 ml of pH 
2 . 2  
diluting for analysis .  ( d) A one ml
 sample was then applied to b
oth 
the 15 cm and the 150 cm temperatur
e controlled columns on the a
nalyzer . 
Total analysis time for each peptid
e was 22 . 5  hours . ( e ) The numb
er of 
micromoles of each amino acid in 
the peptides was de termine d . 
Most of the peptides were calcula
ted to be at least eighty perce
nt 
pure . The notable exception was pe
ptide AF-1 .  The purity of ·pep
tide 
AF-1 was de termined by a single s
tage of Edman degradation, and th
e 
results sugge sted that this peptid
e contained at least three cont
am-
inating peptides .  
Table II 
Amino acid composition of peptides obtained by chyrnotryptic hydrolysis of oxidized nifungin 
The composition of each peptide is _  given in terms of micromoles of the constituent amino acids in the 
aliquot analyzed. Values for the major constituents are underlined. Values for residues present in 
less than 0.01 of a micromole are omitted. Molar ratio s  are shown in parentheses and are calculated 
without any correction for destruction of amino acids during hydrolysis. The peptides are numbered 
as in the test. 
Amino acid Peptide Peptide Peptide Peptide Peptide Peptide Peptide Peptide Peptide Peptide Peptide 
re sidue AFl AF2 AF3 AF4 AF5 AF6 AF? AF8 AF9 AFlO AFll 
Lysine 0. 4h 0. 38 0.19 (1) 0. 02 0. 25(1)  0.15 ( 1) 0. 23 ( 2 )  0. 45 ( 2 )  0. 3 2 ( 1) 0. 15 0. 5.3 ( 4) 
Histidine 
Arginine 0.08 
Cysteic Acid 0. 55 0. 18 0. 35 ( 2 ) 0.01 0. 26( 1)  0.15 (1 )  �( 2) 0. 51 ( 2 )  0. 01 0.05 0.13 (1 )  
A spartic Acid 0. 29 0.14 -- -- 0.04 0.12 ( 1) 0. 01 0. 02 0. 01 0.09 0. 23 ( 2 ) 
Threonine o. ,o -- -- 0. 57( 1)  o. 45 ( 2) 0. 05 
Serine 0.12 -- -- 0. 01 0.04 -- -- -- 0. 04 
Glutamic Acid 0.14 -- -- -- 0. 02 - - 0. 01 -- 0. 28( 1) 
Proline 0. 10 
Glycine 0.19 -- -- 0.01 0.13 0.12 ( 1) �(1) 0. 23 (1) 0. 02 
Alanine 0.17 0.15 0.13 ( 1) 0. 15( 1) 0. 50( 2 )  0. 03 0. 01 -- 0. 27 (1 )  
Table II  continued on  page 47  
Table II continued 
Amino acid PeDtide Peptide Peptide Peptide Peptide Peptide Peptide Peptide Peptide Peptide Peptide 
re sidue AFl AF2 AFJ AF4 AF5 AF6 AF7 AFB AF9 Ano AFll 
Half Cystine 
Valine o . os 
I soleucine 0 . 07  -- 0 .15 ( 1) o . os o . os -- -- -- -- 0 . 07 0 . 12 ( 1) 
Leucine 
Tyro sine 0 . 12 0 . 19 -- 0 . 5 7 ( 1) 0 . 02 -- .£:.22( 1) -- -- 0 . 03 
Phenylalanine 0 . 13 
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The Edman Degradation - The usual manner of presenting amino acid 
sequence data is to express the results in terms of the molar ratio of 
amino acids remaining after successive degradations . In this investi­
gation however, the data will be expressed as the number of micromoles 
of amino acids present after each stage of degradation. This method of 
presentation w�s necessitated _ by the lack of uniformity in sampling 
after each degradation . The lack of uniformity was not intentionalJ 
and a detailed review of sampling technique will be given in the 
discussion section. 
The amino acid sequence of those peptides selected for analysis 
in this investigation are presented in the following order: (a) The 
amino acid composition, without regard to order, is given first . (b) 
Directly below the composition is the number of residues of each acid 
present as shown in Table II. (c) The Edman degradation is then listed 
according to the_ number of significant stages in the sequence analysis. 
The results of each stage are expressed in micromolar quantities. The 
amino acid " subtracted" from the peptide after each sequence stage is 
identified by underlining its value � (d) The amino acid sequence is 
then given for the peptide . Any pertinent information concerning the 
peptide follows the amino acid sequence. 
From the eleven chymo tryptic peptides originally isolated, six 
were selec ted for amino acid sequence studies using the Edman degrada­
tion. These included peptides AF-3, AF- 4, AF-6, AF- 7 ,  AF-8 and AF-9. 
Peptide AF-3 
Amino Acid Composition Lys Cyso3H 
Number of Residues 2 . 0 2 .0 
Edman Degradation 
Stage one • 3.5 • 63 
Stage two . 27 • .53 
S tage three . 1.5 . JO 
Stage four a a 
Stage five . 17 . • 62 
Amino Acid Se�uence 
Ala-Ile 
a. Data not available .  Recorder malfunction. 
49 
Ala Ile 
1 . 0  1 . 0  
. 01 . 12 
. oo . oo 
. oo . oo 
a a 
. oo . oo 
( CyS03H,  Cyso3
H ,  Lys , Lys) 
The stepwise removal of the alanine and isoleucine residues from 
AF-3 was evident from the data for the Edman degradation. Interpreta­
tion of the data beyond the second stage of the degradation was dif­
ficult, therefore only two residues were assigned positions in the 
peptide . 
Peptide AF-4 
Amino Acid Composition 




Amino Acid Sequence 
Thr 













The position of alanine and threonine in peptide AF-4 is  clearly 
shown by the data. The specificity of alpha chymotrypsin for the 
carboxyl side of the aromatic amino acids suggested tyrosine as the 
COOH-terminal residue, and the data presented verify this. 
Peptide AF-6 
Amino Acid Composition 
Number of Residues 
Edman Degradation 
Stage one 
S tage two 
S tage three 























Peptide .AF-6 was the trailing peptide initially separated from 
AF-5. The sequence of amino acids in this peptide was readily defined 
by the Edman degradation. The C00H-terminal position of cysteic acid 
is unusual based on the specificity of alpha chym.otrypsin. 
Peptide .AF-7 
Amino Acid Composition 





















The position of glycine as the NH2-terminal residue in peptide AF-7, 
and the position of the lysine residue as the penultimate residue is well 
documented by the data presented. The cysteic acid residues in the 
peptide have not been assigned positions in the sequence. Assuming 
that tyrosine was the COOH-terminal in the peptide, the cysteic acid 




Amino Acid Composition Lys Cyso3H Gly 
Number of Re sidues 2. 0 2. 0 1. 0 
Edman Degradation 
Stage one . 12 . 26 . 11 
Stage two . 23 . 61 . 11 
Stage three . 05 . 51 . 05 






Following the first stage of Edman degradation , only cysteic acid 
remained in a. 2_: l ratio with glycine. This indicated that lysine was 
the NH2-terminal residue in peptide AF-8 . After the s econd stage 
degradation, both lysine and cysteic acid showed increases because of 
sampling methods, but the glycine level did not increas e  proportionately. 
On this basis glycine was assigned the second position in the amino 
acid sequence. The third stage of analysis indicated that another 
lysine was removed from the peptide. The final two positions in the 
peptide were therefore assigned to the remaining cysteic acid residue s. 
- - ---- .. . . .... 
Peptide AF-9 
.Amino Acid Composition 




Amino Acid Sequence 
- .. :...- �-. - -· 
Lys Glu Ala 
1. 0 1. 0 1. 0 
. 02 . 52 . 51 
. oo . 55 . 05 
Lys-Ala-Glu 
This peptide was the only one foun
d to possess no absorption in
 
the ultraviolet range at 2760 A. It
s presence was determined by t
he 
ninhydrin method with its absorban
ce measured at 5700 A .  
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-SH Group Determination - The results of the determination of the 
reactive -SH groups in the unoxidized nifungin are s hown in Table III. 
pH 
7. 0 
4 . 6  
Table III 
Titration of 3 ml of 6 . 4 x 10-5M p-Hydroxymercuribenzoate 
with nifungin 
5. 7 X 10-\i 0 . D . @ 250 nm 0 . D .  corrected 
nifungin, ml for dilution 
0. 000 0 . 293 0. 293 
0. 025 0 . 290 0. 292 
0. 125 0. 289 0. 301 
0.'000 0. 178 0. 178 
0. ·100 0. 178 0. 184 
0. 100 after 50 minutes 0 . 179  0 . 185 
At pH 7 . 0 there was no tendency in the absorption to change with 
time following eac h addition of the peptide solution to the cuvettes. 
Similarly , at pH 4 . 6 only a 0 . 001 change in optical density occurred 
after the fifty minute reaction period. Since the molarity of the 
antifungal peptide was equal to that of the reduced glutathione ( 5. 7  x 
10- �) , the 0. 100 ml used at pH 4 . 6 s hould have completed the titration . 
On the basis of this analysis , it was concluded that nifungin possessed 
no reactive -SH groups , and the eight half-cystine residues found in the 
peptide were bound through four _disulfide bonds. 
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DISCUSSION 
The disruption of disulfide bonds by oxidation with performic 
acid has been a standard technique in protein chemistry since its 
introduction by Sanger (23) .  The value of the method is that cysteic 
acid and the oxidation products of cystine contain sulfur in a stable 
oxidation stage. In this stable state these amino acids can be deter­
mined wi th precision in acid hydrolyzates of proteins and peptides. 
The major shortcomings of the method were not a problem in this investi ­
gation because nifungin contained no tryptophan residues. The reagent 
is capable of transforming tryptophan residues into a number of deriva­
tives in which the indole ring has been ruptured (29) . 
Performic . acid is a powerful oxidizing agent. In addition to the 
sulfur containing amino acids, it will oxidize the phenolic group of 
tyrosine and the hydroxyl group of threonine and serine . Hirs noted 
that perf'ormic acid involves the oxidation of cysteine to cysteic acid 
(29) .  The conversion o f  the disulfide bond in cystine to cysteic acid 
proceeds at a somewhat slower rate . . The modification of tyrosine pro­
ceeds at a rate slower than either of the other conversions. 
The presence of halide ions in the peptide reaction mixture 
interferes with the oxidation procedure . The reagent is capable of 
converting halides to the corresponding halogen . These halogens sub­
sequently attack tyrosine with the formation of a mixture of halo­
tyrosine derivatives. 
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The Dowex 50 x 2 and the companion Dowex SO W x 2 cation exchange 
resins have been used most frequently for the separation of peptide 
mixtures. These resins however, have some disadvantages. Most nota­
ble among these is their strong adsorption capacity for peptides which 
contain the cyclic am ino acid residues, i. e. tyrosine and phenylalanine. 
The use oi' alpha chymo trypsin in this investigation made the recovery 
of the peptides with these amino acids critical to the sequence deter­
mination. For this reason the Dowex resins were not employed for the 
separation of the chymotryptic peptides. 
The resin chosen for this investigation was the weakly acidic 
carboxylic exchange resin, Amberlite XE64 (also known as IRC50). This 
resin has limited use for peptide separation, and has been employed 
primarily for the fractionation of proteins (43) . It has also proven 
useful in the separa tion of ei ther large peptides of highly basic 
peptides not readily fractiona ted on ion exchange resins similar to 
Dowex SO x 2. 
The choice of Amberlite XE64 for the separation of' peptides in this 
investigation was based on the follOwing considerations. The Amberlite 
XE64 resin had been successfully used in the MDPH laboratory for the 
isolation and purification of the antifungal peptide. Conditions for 
the effective use of the resin had been studied, and suitable companion 
buffer systems had been investigated. The large number of basic and 
aromati c amino acid residues in the antifungal peptide necessitated the 
use of  an lon exchange resin whose primary exchange groups possessed a 
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relatively high pKa. The carboxylic acid groups of the XE64 resin 
are half-ionized at pH 6. 0, and complete dissociation occurs at pH 
level greater than 7. 0. The use of this resin is therefore practical 
with pep tides whose net charge is essentially positive in the pH 5 . 7  
range. (c) Preliminary studies using Dowex 50 x 2 for separation of 
the peptides from nifungin confirmed the strong adsorption of some 
nifungin peptides to this resin. The presence of ninhydrin positive 
materials on the Dowex 50 x 2 resin following elution with phosphate 
buffers at strengths up to 0. 9 M made its use appear impractical for 
this investigation. 
Alpha chymotrypsin catalyzes the hydrolysis of the peptide bonds 
between the C00H group of tyrosine, phenylalanine or tryptophan and 
the NH0 group of the adjacent amino acid (44). It also catalyzes the 
hydrolysis of esters, amides and other acyl derivatives. Slower hydro­
lysis has also been found to occur at the carboxyl group of other amino 
acids inc.luding lysine, serine, threonine and cysteic acid. The rate 
at which this enzyme attacks susceptable sites on the substrate is 
influenced by the amino acid residue adjacent to the susceptable bond 
and the conditions used to carry out the hydrolysis. 
In this investigation the specificity of alpha chymotrypsin was 
found to be more broad than anticipated. Four of the six peptides 
examined in the study possessed no tyrosine or phenylalanine residue 
in their s tructure. 
Preliminary experiments separating the chymotryptic peptides from 
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nifungin on Amberlite XE64 were followed by measurement of both the 
0 0 
ultraviolet and visible absorption of the eluates at 2760 A and 57 00 A. 
The absorption measurements at 57 00 A were made after the eluates had 
been reacted with ninhydrin. Results from these experiments showed 
good correlation between the two series. (Figure 2 and 3). Based 
on the observed correlation , the chymotryptic peptides isolated for 
this study were identified solely for their absorption at 2760 A. The 
one exception to this was peptide AF-9 which had no visible absorption 
at 2760 A and required the ninhydrin assay for identification. 
The reason for the correlation between the two absorption measure­
ments was not known. Normally , for peptides and proteins, absorption 
in the 2760 A region is selectively based on the presence of tyrosine, 
phenylalanine and tryptophan in the structure. Conversely, absorption 
0 
at 5700 A based on the ninhydrin reaction is general in nature where 
the characteristic Ruhemann ' s  Purple is produced when the amino nitro­
gen in the peptide reacts with two moles of ninhydrin reagent. 
Possible explanations for the observed correlation are: (a) 
contamination ·of peptides not containing the aromatic amino acids by 
traces of tyrosine or phenylalanine; (b) measurable absorption in 
0 
2760 A region based on peptide concentration, where the actual absorp-
0 0 
tion maximum is at a lower wave length, i. e. 2500 A or 2100 A ;  or (c) 
absorption in the 2760 A region influenced by the peptide bond. 
The successive steps involved in the subtractive method of Edman 
degradation have been described in the method section. The purpose 
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here is to discuss the scope and limitations of the method as applied 
to the results obtained in this investigation. 
The two conditions essential for the coupling of the peptide 
with phenylisothiocyanate are an alkaline pH and a solvent system 
in which both the peptide and the reagent are appeciably soluble. 
In the former, the alkaline pH is required to insure that the amino 
group which attacks the thiocarbonyl groups of phenylisothiocyanate 
is unprotonated. In the latter case a number of different solvents 
have been used ( 45) . The combination of pyridine,  water and N-ethyl 
morpholine in the ratio (150: 100: 29) used in this investigation appears 
to be the solvent system of choice in the current literature. 
The complete coupling reaction can be achieved by the use of a 
50 fold excess of phenylisothiocyanate at 37° for 2 hours ( 45) . This 
same reaction for the peptides of nifungin was carried out using only 
a 10 fold excess of the phenylisothiocyanate. The effect of this 
decrease in the · amount of reagent is unknown, however , it is thought 
that the reaction leading to the formation of the phenylisothiocar-
bamyl peptide PTC was not complete. · Statistically , this would limit 
the quantity of PTC available for cyclization later in the reaction. 
Further , continuous sampling of unreacted peptide would lead to confusing 
results. 
The importance of excluding oxygen during the coupling reaction 
has been stressed by Edman (31, 46) . Atmospheric oxygen is capable of 
replacing the sulfur in the thiocarbonyl group of the PT C. According 
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to Konit_;sberg ( 45) the oxygen of Lhe phenylcarbamyl group will not 
a t, t,ack the carbonyl carbon of the amino terminal acids at,  any 
appreciable rate under the conditions used for cyclization. If the 
phenylcarbamyl peptide is formed, but does not cyclize, it will inter­
fere with the interpretation of the results from the subsequent stages. 
Since the phenylisothiocyanate has already bound the free amino group 
in the peptide, it cannot be degraded further. The uncyclized phenyl­
thiocarbamyl will be carried along in the peptide fraction. Upon acid 
hydrolysis, this fraction will yield some portion of all the amino acids 
present in the original peptide. This will occur no matter how far the 
degrada tion has been carried out. I f  some phenylcarbamyl peptide is 
formed during each coupling reaction the accumulation oi' these products 
during several ·stages will contribute to the non-integral loss of the 
NH
2
-terminal amino acid that is being removed. 
After the phenylthiocarbamyl peptide was formed, the reaction 
mixture was extracted 3-5 times with 2. 0 ml of benzene. These extrac­
tions removed excess phenylisothiocyanate, phenylurea and residual 
solvent. The presence of benzene at this point is believed to further 
aid the removal of the last traces of water. The benzene-water 
azeotropic mixture formed evaporates at a lower temperature than water 
alone. 
' Phe requirement for maintaining anhydrous conditions during 
cycl iza tion has been stressed in the literature ( 46) . These conditions 
are necessary in order to avoid cleavage of the acid sensitive bonds 
in the remainder of the peptide . 
The cyclization step for the nifungin peptides was carried out 
under mild conditions using 100 microliters of anhydrous trifluoro­
acetic acid at 25° for one hour. Although mild, these conditions have 
been found to be effective in obtaining complete cyclization of all 
potentially degradable material ( 45) . 
Following cyclization, the trifluoroacetic acid was evaporated 
in a nitrogen stream and the residue was dissolved in o . 4  M acetic 
acid. The acetic acid solution containing the phenylthiohydantoin 
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was extracted 3 times with 2 ml of benzene saturated with 0. 4 M acetic 
acid. This extraction removes the phenylthiocarbamyl amino acids and 
the phenylthiohydantoins of most acidic and neutral amino acids except 
for the derivatives of arginine, histidine, aspartic acid, serine, 
threonine and cysteic acid. While these derivatives can be extracted 
into ethyl acetate, care must be taken with this solvent. Ethyl acetate 
will extract peptide materials as well as amino acids; this is particu­
larly true for peptides containing non-polar amino acid residues. 
The use of the subtractive method for the determination of amino 
acid sequence as used in this investigation was only partially success­
ful. Side reactions which led to the accumulation of products either 
not capable of reacting with phenylthiohydantoin or undergoing cycliza­
tion made the data for some of the peptides difficult to interpret. 
These difficulties can be overcome however, by purification of the 
remaining peptide in the aqueous solution before removing an aliquot 
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for hydrolysis and amino acid analysis.  Konigsberg and Hill ( 47) 
purified the remaining peptides in human hemoglobin from their side 
reaction products using the following method. After cyclization and 
extraction of the water solution with benzene, the aqueous phase was 
adsorbed onto a 0. 3 x 6 cm column of Dowex 50 x 2 in the hydrogen form. 
The column was first washed with 4. 0 ml of water, and then eluted with 
a small quantity of pyridine acetate buffer to remove the peptide. The 
pyridine buffer was 1 M in pyridine at pH 5 . 6 .  An aliquot of the 
purified peptide was then taken for amino acid analysis. The material 
recovered from the water wash was ninhydrin negative , but after acid 
hydrolysis, all the amino acids present in the parent peptide were 
found. This indicated that the materials eluted in the water wash was 
a peptide derivative containing no free amino groups. This procedure 
cannot be applied to acidic peptides containing cysteic acid as these 
peptides are not adsorbed nor can it be used with peptides that have 
many basic or aromatic residues. While the method does not permit the 
quantitative determination of the subtracted amino acid it does eliminate 
a major' source of contamination. 
In this investigation . the purification and sampling method described 
was not employed .  The limitations of the method involving those peptides 
containing cysteic acid and aromatic amino acid residues were too closely 
related to the characteristics of the nifungin peptides . An aliquot of 
the aqueous phase thought to correspond to 10 percent of the remaining 
peptide after each cyclization was withdrawn for hydrolysis and amino 
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acid analysis. However, as the results showed, this sampling technique 
proved to lack uniformity and gave analyses which were difficult to 
interpret through a series of degradations . The lack of uniformity 
in sampling is believed to have been caused by several factors. 
Larger peptides which undergo the Edman degradation tend to retain 
their solubility in aqueous solution. Many small peptides similar in 
size to the nifungin peptides become insoluble as they are degraded 
and accurate sampling of these peptides is therefore difficult ( 45) . 
The presence of uncyclized phenylthiocarbamyl peptide in the aqueous 
phase can lead to the removal of more side products and unreacted 
materials than peptide ( 45) . 
The spectrophotometric titration of the -SH groups in nifungin 
with p-hydroxymercuribenzoate indicated that no reactive -SH groups 
were present in the molecule. The method has the advantage that the 
ultraviolet absorption of the mercury-sulfur bond formed between the 
peptide and reagent can be measured directly in the region of 250 run. 
Benesch et  al. ( 48)  have indicated that the p-hydroxymercuribenzoate 
is the only compound of its type which shows an adequate increase in 
absorption in the useful spectral region as the result of mercaptide 
forma t ion . 
' l ' h <� L i tration is carr ied out a L  two pH levels . The reaction at 
pH 7 . 0  i3  used to allow the readily exposed -SH groups in the protein 
structure to react with the mercury compound. At the lower pH level 
( 4 . 6 . ) , the titration is a timed reaction in which any groups which 
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may be masked in the protein matrix are given an opportunity to undergo 
reaction with the �ercury compound. 
The size of the nifungin peptide was such that all of the -SH 
groups should have been readily accessible to the p-mercuribenzoate 
reagent almost instantaneously, at either level. If there were any 
reactive -SH groups present, an end point should have been reached 
at pH 4 . 6 . after the fifty minute time period allotted. Depending 
upon the size of the protein being titrated, the end point for reactive 
-SH groups present will be reached from several minutes to four or 
five hours. 
The complete amino acid sequence of the antifungal peptide nifungin, 
cannot be determined from the results of a single enzyme digestion as 
carried out in the current investigation. However , the results from 
this study can be used in two ways, (1) The sequence of amino acids 
obtained in this study can be compared with the sequence of amino acids 
obtained from the digestion of the same antifungal peptide with a dif­
ferent proteolytic enzyme. A comparison of this type involving all of 
the purified peptides from each digestion could theoretically yield the 
complete primary structure of the nifungin molecule. (2) The results of 
this study can be used to partially characterize the compound under 
investiga tion. 
In the current study, the results were used to make the following 
observa tions about the antifungal peptide. 
(a) The antifungal peptide is basic in nature and has 49 amino 
acid residues in its structure. 
(b) The peptide is composed of 1 . 5% ash and moisture, and 85% 
amino acid residues. The remaining 13% was not identified in this 
investiga tion . 
(c) The peptide does not possess any free -SH groups, but has 
four disulfide bonds in its molecular structure. 
(d) There are no tryptophan , histidine or methionine residues 
in the pep tide. 
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( e) l• 'our chymotryptic peptides examined in this study had COOH­
terminal residues which did not correspond to the expected chymotryp­
sin specificity. While random fragmentation was anticipated, the level 
here appeared excessive. Based on this, and preliminary studies in­
volving the nifungin terminal residues, the antifungal peptide was 
thought to have a rather complex structure. 
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SUMMARY 
In this study the antifungal peptide, nifungin, was investigated 
and partial characterization was achieved. 
The amino acid composition of the peptide was determined. Analyses, 
following acid hydrolysis, accounted for 85% of the peptide structure 
as amino acid residues. An additional 1 . 5% was found as ash and moisture. 
The remaining portion of the structure was not identified. 
The peptide was oxidized with performic acid to disrupt the disulfide 
bonds, and subsequently digested with alpha chymotrypsin. The peptide 
mixture was separated on Amberlite XE64 resin with ammonium acetate 
buffers. Eleven chymotryptic peptides were isolated by this method. 
Six peptides were selected for amino acid sequence analysis and partial 
characterization by the Edman degradation, using the subtractive method. 
The chymotryptic peptides chosen for analysis possessed unusual end-
group residues in some instances based on enzyme specificity. 
Spectrophotometric titration of nifungin with p-hydroxymercuri­
benzoate showed that the antifungal peptide possessed no free -SH 
groups suggesting that the half-cystine residues in the molecule were 
all involv ed in di°sulfide linkages. 
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